Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 20,14120,160 of 20,252 grants

Active NON-SBIR/STTR RPGS
Identifying new drivers of ovarian cancer from the non-coding genome by converging germline risk variants and somatic mutations
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT The goal of the proposed research training program is to provide tailored additional training to facilitate successful career development throughout the co...

$2.49M
USD
Completed TRAINING, INDIVIDUAL
Exploiting convergent evolution to design biomarker extraction tools for the prediction of therapeutic response in cancer
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT The effective treatment of drug resistant tumors represents one of the greatest unmet needs in oncology research. The evolution of therapeutic resistance i...

$539.7K
USD
Completed NON-SBIR/STTR RPGS
Optimizing Colorectal Cancer Screening among Patients with Diabetes in Safety-Net Primary Care Settings: Targeting Implementation Approaches
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2021 – 2025

ABSTRACT Patients with diabetes mellitus have an estimated 27% elevated risk of developing colorectal cancer (CRC) and are disproportionately Non-Hispanic blacks (NHBs) and Hispani...

$2.49M
USD
Completed NON-SBIR/STTR RPGS
X-ray/optical tomographic guidance and assessment for pre-clinical radiation Research
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Over the past 10-years, our group has made multi-disciplinary efforts to bridge the technological gap between radiation methods for human treatment and pre...

$3.41M
USD
Active NON-SBIR/STTR RPGS
Eradication of Escaped Variant Tumor Cells for Cancer Immunotherapy
NATIONAL CANCER INSTITUTE Methodist Hospital Research Institute United States 2021 – 2026

Project Summary Recently, we discovered that adoptive transfer of CD39KO tumor-specific (mixed CD4+ and CD8+) T cells, resulted in long-term survival of mice bearing large establis...

$3.69M
USD
Completed NON-SBIR/STTR RPGS
The novel role of microtubule regulators in the DNA damage response
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2025

DNA damage, particularly DNA double strand break (DSB), has detrimental effects on cell survival and genomic stability. In response to DNA damage, the cell activates several evolut...

$360K
USD
Completed NON-SBIR/STTR RPGS
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2024

PROJECT SUMMARY The incidence of esophageal adenocarcinoma (EAC) has risen 10-fold over the past half century and continues to have a dismal prognosis. Known modifiable risk factor...

$996.9K
USD
Completed NON-SBIR/STTR RPGS
The novel role of microtubule regulators in the DNA damage response
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2025

DNA damage, particularly DNA double strand break (DSB), has detrimental effects on cell survival and genomic stability. In response to DNA damage, the cell activates several evolut...

$3.11M
USD
Completed NON-SBIR/STTR RPGS
Proteomic determinants of response to checkpoint blockade in malignant pleural mesothelioma
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2025

PROJECT SUMMARY / ABSTRACT Malignant pleural mesothelioma (MPM) is a fatal cancer of the lining of the lungs that has defeated standard therapies for decades. Immune checkpoint inh...

$5.85M
USD
Completed NON-SBIR/STTR RPGS
Impact of brain estrogens on cognition and brain aging in a non-human primate
NATIONAL CANCER INSTITUTE University of Massachusetts Amherst United States 2021 – 2025

The goal of the parent grant is to characterize the effects of the aromatase inhibitor letrozole (LET) and the brain-selective estrogen prodrug DHED on (1) behavior; (2) brain elec...

$315.7K
USD
Completed NON-SBIR/STTR RPGS
Serial immunotherapy combination to modulate the tumor environment in patients with metastatic gastroesophageal cancer
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Development of effective therapies is an urgent unmet medical need for patients with metastatic gastroesophageal adenocarcinoma (mGEA).The advent of immune...

$6.4M
USD
Completed NON-SBIR/STTR RPGS
Nonlinear performance analysis and prediction for robust low dose lung CT
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2024

1 PROJECT SUMMARY / ABSTRACT 2 Nonlinear algorithms such as model-based reconstruction (MBR) and deep learning (DL) reconstruction have 3 sparked tremendous research interest in re...

$5.13M
USD
Completed NON-SBIR/STTR RPGS
Chemotherapy-driven evolution of the vascular secretome and its role in therapeutic resistance
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Research Center United States 2021 – 2025

PROJECT SUMMARY Our continued inability to develop selective therapies that prevent the emergence of disseminated breast tumor cells into lethal metastases necessitates new approac...

$4.03M
USD
Completed NON-SBIR/STTR RPGS
Chemotherapy-induced vascular cognitive impairment: role of endothelial senescence
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2021 – 2025

Project Summary Many long-term survivors of cancer experience progressive chemotherapy-induced cognitive impairment (CICI, commonly referred to as chemobrain). Importantly, no stra...

$3.32M
USD
Completed NON-SBIR/STTR RPGS
Novel small molecule USP7 Inhibitors for p53 activation and cancer therapy
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2025

Project Summary: The long-term objective of this project is to develop a novel targeted therapy for human cancers by reactivating the tumor suppression pathways.Although p53 is fre...

$3.71M
USD
Completed OTHER RESEARCH-RELATED
Optimizing Colorectal Cancer Screening among Patients with Diabetes in Safety-Net Primary Care Settings: Targeting Implementation Approaches
NATIONAL CANCER INSTITUTE Rbhs-Robert Wood Johnson Medical School United States 2021 – 2022

ABSTRACT Patients with diabetes mellitus have an estimated 27% elevated risk of developing colorectal cancer (CRC) and are disproportionately Non-Hispanic blacks (NHBs) and Hispani...

$1.57M
USD
Completed OTHER RESEARCH-RELATED
Elucidating the role and mechanisms by which collagenase producing intestinal bacteria promote colorectal cancer recurrence and metastasis following surgery.
NATIONAL CANCER INSTITUTE University of Chicago United States 2021 – 2025

PROJECT SUMMARY / ABSTRACT Colorectal cancer (CRC) is a major health concern with nearly 2-million new cases of CRC diagnosed worldwide in 2019.While surgical resection of the prim...

$2.42M
USD
Completed NON-SBIR/STTR RPGS
Remotely controlled listerial bactodrones for cancer immunotherapy
NATIONAL CANCER INSTITUTE University of Wyoming United States 2021 – 2022

PROJECT SUMMARY Attenuated and avirulent strains of Listeria monocytogenes (Lm), that are delivered via intravenous injections, accumulate and propagate in primary tumors and metas...

$1.86M
USD
Completed NON-SBIR/STTR RPGS
Bcl-2 as a target in cancer
NATIONAL CANCER INSTITUTE Oregon State University United States 2021 – 2022

Project Summary Bcl-2, an anti-cell death protein, is overexpressed in about 40% of all human cancers and contributes to the development and progression of cancer.Overexpression of...

$1.74M
USD
Completed NON-SBIR/STTR RPGS
Proteomic determinants of response to checkpoint blockade in malignant pleuralmesothelioma
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2025

PROJECT SUMMARY / ABSTRACT Malignant pleural mesothelioma (MPM) is a fatal cancer of the lining of the lungs that has defeated standard therapies for decades.Immune checkpoint inhi...

$4.54M
USD